What is the best method for hearing screening in newborns?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Method for Newborn Hearing Screening

The best method for hearing screening in newborns is a two-stage protocol using otoacoustic emissions (OAE) followed by automated auditory brainstem response (ABR) for those who fail the initial OAE screening. 1

Recommended Screening Protocol

Two-Stage Approach

  • First stage: Otoacoustic emissions (OAE) testing for all newborns
  • Second stage: Automated auditory brainstem response (ABR) for infants who fail the initial OAE test

This two-stage approach offers the best balance between sensitivity and specificity while being practical for universal implementation. The American Academy of Pediatrics recommends that:

  • Screening should be performed no later than 1 month of age 1
  • Comprehensive audiological evaluation should be completed by 3 months for those who fail screening 1
  • Appropriate intervention should begin by 6 months for those with confirmed hearing loss 1

Special Considerations for High-Risk Infants

  • NICU infants admitted for more than 5 days should have ABR included in their initial screening to detect neural hearing loss 1
  • Infants who fail automated ABR testing in the NICU should be referred directly to an audiologist 1

Effectiveness of Two-Stage Protocol

The two-stage OAE/ABR protocol has demonstrated significant benefits:

  • Reduces the age of identification of hearing impairment from 12-13 months to 3-6 months 1
  • Decreases the age of hearing aid fitting from 13-16 months to 5-7 months 1
  • Provides good specificity (98.8%) while maintaining reasonable sensitivity (66.7%) 2

However, it's important to note that this protocol has limitations:

  • The two-stage protocol may miss approximately 11% of affected ears 3
  • About 23% of infants with permanent hearing loss at 9 months of age might pass the A-ABR screening 4

Implementation Considerations

For optimal screening outcomes:

  • Equipment must be well-maintained
  • Staff should be thoroughly trained
  • Quality control programs should be in place to reduce false positives 3
  • Complete screening should be performed on both ears, even if only one ear failed initially 1

Follow-up Protocol

  • Infants who fail in-hospital screening should be referred for repeat testing between 2-8 weeks after discharge 1
  • All infants with risk factors for hearing loss should have at least one diagnostic audiological assessment by 24-30 months, even if they passed newborn screening 1
  • More frequent assessment may be needed for children with certain risk factors (CMV infection, syndromes associated with progressive hearing loss, family history) 1

Common Pitfalls to Avoid

  1. Loss to follow-up: 6-15% of infants who fail screening are lost to follow-up, and 13-31% of infants who fail initial screening do not return for definitive testing 1

  2. False reassurance: Passing newborn hearing screening does not eliminate the need for ongoing monitoring, especially in high-risk infants 1

  3. Parental anxiety: False positives can cause significant parental anxiety, with 25-50 false positives for each true case in low-risk populations 1

  4. Missing mild hearing loss: Standard screening protocols are primarily designed to detect moderate to severe hearing loss and may miss milder cases 1

By implementing a systematic two-stage OAE/ABR screening protocol with appropriate follow-up mechanisms, healthcare providers can effectively identify newborns with hearing impairment and facilitate early intervention, which is crucial for optimal speech and language development.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.